杂志简称：front pharmacol
中文译名：《药理学前沿》
收录属性：scie（2024版）, 英文期刊,
自引率：4.40%
投稿方向：医学、pharmacology & pharmacy 药学
SCI/E期刊基本信息
出版周期：不定期 地区：瑞士
中科院分区：2区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：OA期刊
国际标准刊号：ISSN1663-9812；EISSN1663-9812
杂志语言：英语
出版国家：瑞士
杂志官网 联系方式
出版地址：AVENUE DU TRIBUNAL FEDERAL 34,LAUSANNE,SWITZERLAND,CH-1015
杂志邮箱：
投稿网址：https://www.frontiersin.org/submission/SubmissionHome.aspx?domainId=1&fieldId=62&specialtyId=0&entityType=1&entityId=176
杂志官方网址：https://www.frontiersin.org/journals/pharmacology
出版商网址：http://frontiersin.org
杂志投稿要求
投稿须知【杂志社官方网站信息】
Scope & Mission
Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Pharmacology is a medical science, as was recalled in the anniversary address for the 50th Spring Meeting in Mainz of the German Pharmacological Society in March 2009. This science, of the effect of medicinal bodies, gives us the handle to clarify the fundamental processes of life. It is also the science studying the interactions between chemicals and living beings directed to prevent, ameliorate or cure the deleterious consequences of their diseases, thereby providing medicine with weapons against diseases. Those major targets offer the opportunity to segment the field not only in studies considering pure basic topics but also by integrating basic and clinical science. This journal's editorial policy aims at identifying the most productive research projects through an evaluation by the scientific community and emphasizing proper use of translational science at both preclinical and clinical levels. Editors encourage collaboration between clinicians and basic scientists and welcome papers issued from a collaborative strategy between the academic and the private industrial sectors that could assist in the reversal of the current decline in the production of original medicines.
Frontiers in Pharmacology is a member of the Committee on Publication Ethics.
Submission
Frontiers in Pharmacology is composed of the following Specialty Sections:
Cardiovascular and Smooth Muscle Pharmacology
Drug Metabolism and Transport
Drugs Outcomes Research and Policies
ELSI in Science and Genetics
Ethnopharmacology
Experimental Pharmacology and Drug Discovery
Gastrointestinal and Hepatic Pharmacology
Inflammation Pharmacology
Integrative and Regenerative Pharmacology
Neuropharmacology
Obstetric and Pediatric Pharmacology
Pharmacoepidemiology
Pharmacogenetics and Pharmacogenomics
Pharmacology of Anti-Cancer Drugs
Pharmacology of Infectious Diseases
Pharmacology of Ion Channels and Channelopathies
Predictive Toxicology
Renal Pharmacology
Respiratory Pharmacology
Translational Pharmacology
The specialty sections of Frontiers in Pharmacology welcome submission of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review, Technology and Code, Erratum, Policy and Practice Reviews, Curriculum, Instruction, and Pedagogy, Policy Brief and Protocols.
When submitting a manuscript to Frontiers in Pharmacology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.